The company
Skye Bioscience, Inc.
SKYE · Nasdaq
SKYE stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 66.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $1.8M
- Officials’ trades on record
- 0
- Institutions holding
- 43 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| 5am Partners Vii, Llc10% owner | sold | 114,851at $1.61 | 23 Sep 2026filed 24 Sep 2026 |
| 5am Partners Vii, Llc10% owner | sold | 4,528at $1.61 | 23 Sep 2026filed 24 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 114,851at $1.61 | 23 Sep 2026filed 24 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 4,528at $1.61 | 23 Sep 2026filed 24 Sep 2026 |
| 5am Partners Vii, Llc10% owner | sold | 27,612at $1.65 | 22 Sep 2026filed 24 Sep 2026 |
| 5am Partners Vii, Llc10% owner | sold | 1,088at $1.65 | 22 Sep 2026filed 24 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 27,612at $1.65 | 22 Sep 2026filed 24 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 1,088at $1.65 | 22 Sep 2026filed 24 Sep 2026 |
| 5am Partners Vii, Llc10% owner | sold | 32,607at $1.91 | 16 Sep 2026filed 18 Sep 2026 |
| 5am Partners Vii, Llc10% owner | sold | 1,285at $1.91 | 16 Sep 2026filed 18 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 32,607at $1.91 | 16 Sep 2026filed 18 Sep 2026 |
| Andrew J. SchwabDirector, 10% owner | sold | 1,285at $1.91 | 16 Sep 2026filed 18 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| 5AM Venture Management, LLCunchanged · filed 14 Aug 2026 | 9,681,763$6.7M | 00.0% |
| Versant Venture Management, LLCunchanged · filed 12 Aug 2026 | 2,007,704$1.4M | 00.0% |
| BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026 | 1,575,243$1.1M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 763,882$529K | -575−0.1% |
| SPHERA FUNDS MANAGEMENT LTD.unchanged · filed 14 Aug 2026 | 678,928$471K | 00.0% |
| PLATINUM INVESTMENT MANAGEMENT LTDunchanged · filed 13 Aug 2026 | 233,095$162K | 00.0% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 232,874$161K | -53,257−18.6% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 218,055$151K | -59,201−21.4% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 198,524$138K | -59,676−23.1% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 104,229$72K | 00.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.